5.000
+0,00%
2026-10-19
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -60.8% | -8.6% | 1 / 3 | -18.6% | -4.80 pp | -2.63 pp | +5.2% | 0.42 | 7.52 | 114 | −18,6% | 8,3 | −40,1% | 7.52 | 7.69 | −2,2% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 5.000 (close price on 2026-10-19)EPS (TTM): 664,7
Financial charts
1.Revenue & growth
VND bn114Q2/26
1.Revenue & growth
VND bn114Q2/26
2.Profit & growth
VND bn7,61Q2/26
3.Profit mix (Penman)
VND bn60,1Q2/26
4.Margins & cost structure
%15.1%Q2/26
5.Returns & cash cycle
% · days5.5%Q2/26
6.Earnings quality & cash
VND bn-93,0Q2/26
7.Asset structure
VND bn1.846Q2/26
8.Funding & debt health
VND bn · times1.846Q2/26
9.Revenue backlog
VND bn12,2Q2/26
10.Valuation
times · %10,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %71Q2/26
Adjusted EPS growth, latest quarter
-60.8%
Average adjusted EPS growth, 3 quarters
-8.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
56.0%
Source: vnstockData through Q2/26